A case-control study on the effect of apoliprotein E genotype on head and neck cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 11, 2010, Pages 2839-2846

  De Feo, Emma ^a   Rowell, Jessica ^a,b   Cadoni, Gabriella ^a   Nicolotti, Nicola ^a   Arzani, Dario ^a   Giorgio, Arianna ^a   Amore, Rosarita ^a   Paludetti, Gaetano ^a   Ricciardi, Gualtiero ^a   Boccia, Stefania ^a,c  

^a CATHOLIC UNIVERSITY   (Italy)

^b EMORY UNIVERSITY   (United States)

^c CdC San Raffaele Velletri ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4;

ADULT; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENOTYPE; HEAD AND NECK CANCER; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK REDUCTION;

ADULT; ALCOHOL DRINKING; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTEIN ISOFORMS; RISK FACTORS; SMOKING;

EID: 78549249863     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0624     Document Type: Article

References (43)

1. Mahley RW, Huang Y. Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing. J Clin Invest 2007;17:94-8.
2. Vogel T, Guo NH, Guy R et al. Apolipoprotein E: a potent inhibitor of endothelial and tumor cell proliferation. J Cell Biochem 1994;54: 299-308.
3. Moore LE, Brennan P, Karami S. Apolipoprotein E/C1 locus variants modify renal cell carcinoma risk. Cancer Res 2009;69:8001-8.
4. Mahley RW, Nathan BP, Pitas RE. Apolipoprotein E: structure, function, and possible roles in Alzheimer's disease. Ann N Y Acad Sci 1996;777:139-45.
5. Bennet AM, Di Angelantonio E, Ye Z, et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 2007; 298:1300-11.
6. Brouwers N, Sleegers K, Van Broeckhoven C. Molecular genetics of Alzheimer's disease: an update. Ann Med 2008;40:562-83.
7. Mrkonjic M, Chappell E, Pethe VV, et al. Association of apolipoprotein E polymorphisms and dietary factors in colorectal cancer. Br J Cancer 2009;100:1966-74.
8. Jacobs D, Blackburn H, Higgins M, et al. Report of the conference on low blood cholesterol: mortality associations. Circulation 1992;86: 1046-60.
9. Delahaye F, Bruckert E, Thomas D, Emmerich J, Richard JL. Serum cholesterol and cancer. Is there a casual relationship? Arch Mal Coeur Vaiss 1992;85:37-45.
10. Forones NM, Falcao JB, Mattos D, Barone B. Cholesterolemia in colorectal cancer. Hepatogastroenterology 1998;45:1531-4.
11. Asano K, Kubo M, Yonemoto K, et al. Impact of serum total cholesterol on the incidence of gastric cancer in a population-based prospective study: the Hisayama study. Int J Cancer 2008;122:909-14.
12. Kritchevsky SB, Kritchevsky D. Serum cholesterol and cancer risk: an epidemiologic perspective. Annu Rev Nutr 1992;12:391-416.
13. Wannamethee G, Shaper AG, Whincup PH, Walker M. Low serum total cholesterol concentrations and mortality in middle aged British men. BMJ 1995;311:409-13.
14. Davey Smith G, Ebrahim D. "Mendelian randomization": can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiology 2003;32:1-22.
15. Boccia S, Hashibe M, Gallì P, et al. Aldehyde dehydrogenase 2 and head and neck cancer: a meta-analysis implementing a Mendelian randomization approach. Cancer Epidemiol Biomarkers Prev 2009; 18:248-54.
16. Weinberg JB, Volkheimer AD, Mihovilovic M, et al. Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia. Leukemia 2008;22:2184-92.
17. Slattery ML, Sweeney C, Murtaugh M, et al. Associations between apoE genotype and colon and rectal cancer. Carcinogenesis 2005; 26:1422-9.
18. Chang NW, Chen DR, Wu CT, et al. Influences of apolipoprotein E polymorphism on the risk for breast cancer and HER2/neu status in Taiwan. Breast Cancer Res Treat 2005;90:257-61.
19. Trompet S, Jukema JW, Katan MB, et al. Apolipoprotein e genotype, plasma cholesterol, and cancer: a Mendelian randomization study. Am J Epidemiol 2009;170:1415-21.
20. Kuoppala J, Lamminpää A, Pukkala E. Statins and cancer: a systematic review and meta-analysis. Eur J Cancer 2008;44:2122-32.
21. Chyou PH, Nomura AM, Stemmermann GN, Kato I. Prospective study of serum cholesterol and site-specific cancers. J Clin Epidemiol 1992;45:287-92.
22. Patel PS, Shah MH, Jha FP, et al. Alterations in plasma lipid profile patterns in head and neck cancer and oral precancerous conditions. Indian J Cancer 2004;41:25-31.
23. Marron M, Boffetta P, Zhang ZF, et al. Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk. Int J Epidemiol 2010;39:182-96.
24. Gallì P, Cadoni G, Volante M, et al. A case-control study on the combined effects of p53 and p73 polymorphisms on head and neck cancer risk in an Italian population. BMC Cancer 2009;9:137.
25. Hashibe M, Brennan P, Chuang SC et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev 2009;18:541-50.
26. Seripa D, Signori E, Gravina C, et al. Simple and effective determination of apolipoprotein E genotypes by positive/negative polymerase chain reaction products. Diagn Mol Pathol 2006;15:180-5.
27. Lewellyn CD, Johnson NW, Warnakulasuriya S. Risk factors for squamous cell carcinoma of the oral cavity in young people: a comprehensive literature review. Oral Oncol 2001;37:401-18.
28. Lewellyn CD, Linklater K, Bell J, Johnson NW, Warnakulasuriya S. An analysis of risk factors for oral cancer in young people: a casecontrol study. Oral Oncol 2004;40:304-13.
29. Rodriguez T, Altieri A, Chatenoud L, et al. Risk factors for oral and pharyngeal cancer in young adults. Oral Oncol 2004;40:207-13.
30. Nieminen T, Kähönen M, Viiri LE, Grönroos P, Lehtimäki T. Pharmacogenetics of apolipoprotein E gene during lipid-lowering therapy: lipid levels and prevention of coronary heart disease. Pharmacogenomics 2008;9:1475-86.
31. Mahley RW, Weisgraber KH, Huang Y. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci U S A 2006;103:5644-51.
32. Blennow K, de Leon MJ, Zetterberg H. Alzheimer's disease. Lancet 2006;368:387-403.
33. Anstey KJ, Lipnicki DM, Low LF. Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. Am J Geriatr Psychiatry 2008;16:343-54.
34. Di Angelantonio E, Sarwar N, Perry P, et al, Emerging Risk Factors Collaboration. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009;302:1993-2000.
35. Andreotti G, Chen J, Gao YT, et al. Polymorphisms of genes in the lipid metabolism pathway and risk of biliary tract cancers and stones: a population-based case-control study in Shanghai, China. Cancer Epidemiol Biomarkers Prev 2008;17:525-34.
36. Schatzkin A, Hoover RN, Taylor PR, et al. Site-specific analysis of total serum cholesterol and incident cancers in the National Health and Nutrition Examination Survey I epidemiologic follow-up study. Cancer Res 1998;48:452-8.
37. Jofre-Monseny LO, Minihane AM, Rimbach G. Impact of apoE genotype on oxidative stress, inflammation and disease risk. Mol Nutr Food Res 2008;52:131-45.
38. Talmud PJ, Stephens JW, Hawe E, et al. The significant increase in cardiovascular disease risk in ApoE4 carriers is evident only in men who smoke: potential relationship between reduced antioxidant status and ApoE4. Ann Hum Genet 2005;69:613-22.
39. Dietrich M, Hua Y, Block G, et al. Associations between apolipoprotein E genotype and circulating F2-isoprostane levels in humans. Lipids 2005;40:329-34.
40. Tsuda M, Sanada M, Nakagawa H, Kodama I, Sakashita T, Ohama K. Phenotype of apolipoprotein E influences the lipid metabolic response of postmenopausal women to hormone replacement therapy. Maturitas 2001;38:297-304.
41. Gupta A, Bhatt ML, Misra MK. Lipid peroxidation and antioxidant status in head and neck squamous cell carcinoma patients. Oxid Med Cell Longev 2009;2:68-72.
42. Malorni W, Campesi I, Straface E, Vella S, Franconi F. Redox features of the cell: a gender perspective. Antioxid Redox Signal 2007;9: 1779-801.
43. Hoxha M, Dioni L, Bertazzi PA, et al. Shortened telomeres in subjects with heavy alcohol consumption. Exhibit Hall A-C, Poster Section 39. 44. International Head and Neck Cancer Epidemiology Consortium. Available from: http://inhance.iarc.fr/.